Ventilation of small pediatric patients with high airway resistance and low lung function may trigger the defect, resulting in unexpected high internal oxygen consumption.
The affected devices were manufactured and distributed from February 2012 to December 2012. Hamilton is currently working on a software version to provide reduced oxygen consumption, according to the letter sent to customers.
More Articles on Anesthesia:
Joint Commission Issues Opioid Overuse in Hospitals Alert
Study: Acupuncture Analgesia May Activate Sympathetic Nervous System
Brain Monitoring Device Market Expected to Increase to $1.63B by 2017
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
